Lumenis Proudly Announces its Laser Technologies will be the Focus of More than 20 Presentations at the American Society of L...
March 30 2016 - 9:00AM
Lumenis Ltd., the world’s largest energy-based medical device
company for aesthetic, surgical and ophthalmic applications,
proudly announced today that the company’s laser aesthetic
portfolio will be the focus of more than 20 presentations at the
American Society of Laser Medicine and Surgery (ASLMS) Annual
Conference, being held March 30 to April 3, 2016 at the Hynes
Convention Center in Boston, MA. This also includes new data from
two clinical studies conducted using the latest breakthrough in
hair reduction technology, the LightSheer® INFINITY™ laser system.
As a leader in energy-based technologies, Lumenis’ aesthetic
family of products offers solutions that have revolutionized
procedures in aesthetic medicine. The following platforms will be
highlighted as part of more than 20 talks over the duration of the
conference (see link below for exact dates, times and
locations):
- UltraPulse®, the most powerful CO2 laser in aesthetic
medicine, with its proprietary UltraPulse® technology which enables
the deepest penetration with the lowest energy and used for the
most advanced skin resurfacing and scar revision treatments.
- AcuPulse™, a MultiMode™ SuperPulse™ CO2 laser for ultimate
versatility in CO2 laser treatments.
- M22™, a multi-application platform for the treatment of over 30
skin conditions and hair removal, including four advanced and
clinically proven technologies: IPL with Optimal Pulse Technology
(OPT™), Long Pulsed Nd:YAG, Q-Switched Nd:YAG and ResurFX™
- ResurFX™, the only true fractional non-ablative system for skin
resurfacing and stretch marks treatment*. ResurFX features a 1565nm
fiber laser and a unique CoolScan™ scanner enabling scanning in
one-pass and constant contact cooling.
- LightSheer® INFINITY™, the most advanced dual wavelength hair
reduction system in the market featuring Gold Standard 805nm
wavelength and 1060nm wavelength for darker skin types. The system
integrates the Chilltip™ contact cooling and HIT-vacuum
assisted high speed technology enabling optimal patient comfort
management and treatment speed.
Additionally, the new clinical evaluation data will be presented
during the following sessions:
Sunday, April
3, 2016 |
|
|
9:22 AM – 9:28
AM |
|
Clinical Evaluation of
1060nm Diode Laser Vacuum-Assisted Handpiece without Topical
Anesthetic in all Fitzpatrick Skin Types- Multi-Site Study |
|
Dr. Edward Ross, Dr.
Suzanne Kilmer, Dr. Amanda Lloyd |
|
Scripps Clinic, San
Diego, CA & Laser and Skin Surgery Med Group, Sacramento,
CA |
|
Room: Hynes
Auditorium |
|
10:22 AM – 10:26
AM |
|
Clinical Evaluation of
a Novel Diode Wavelength (1060nm) for the Treatment of
Hypertrichosis |
|
Dr. Haider Bangash, Dr.
Omar Ibrahimi |
|
Connecticut Skin
Institute, Stamford, CT |
|
Room: Hynes 103 |
|
|
“Laser hair removal is one of the largest aesthetic indications
globally. The ability to perform a safe and effective treatment has
had its challenges in the past, particularly in darker skin types.
This multi-site clinical evaluation explored the use of the
vacuum-assisted handpiece of the 1060nm diode laser, without the
use of topical anesthetics, on various skin types,” said Dr. E.
Victor Ross, Dermatologist at Scripps Clinic. “We’re looking
forward to sharing the results with our peers at ASLMS.”
“We’re honored that our platforms will be featured in so many
presentations, along with the announcement of new clinical data,
all of which will spark conversations on best practices and better
patient outcomes,” said Tzipi Ozer-Armon, CEO of Lumenis. “We
continue to invest in advanced, unique and versatile technologies
that enable ever improving clinical results that impact our
patient’s quality of life. I would like to take this opportunity to
thank our KOLs, with whom we work closely and diligently in order
to continuously improve our technologies and protocols and
translate it to better patient care.”
To learn more about Lumenis’ technologies, visit the Lumenis
booth #401.
For a full list of sessions featuring Lumenis products,
including dates, times and location, please visit:
http://www.lumenis.com/Solutions/Aesthetic/Events/american-society-of-laser-medicine-and-surgery-conference-aslms.
*ResurFX is cleared by the USA Food and Drug Administration for
coagulation of soft tissue and skin resurfacing.
About Lumenis
Lumenis is a global leader in the field of minimally-invasive
clinical solutions for the Surgical, Ophthalmology and Aesthetic
markets, and is a world-renowned expert in developing and
commercializing innovative energy-based technologies, including
Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For
nearly 50 years, Lumenis' ground-breaking products have redefined
medical treatments and have set numerous technological and clinical
gold-standards. Lumenis has successfully created solutions
for previously untreatable conditions, as well as designed advanced
technologies that have revolutionized existing treatment methods.
For more information visit: www.lumenis.com.
For further information:
Glenn Silver
Lazar Partners Ltd.
(646) 871-8495
LUMENIS LTD (NASDAQ:LMNS)
Historical Stock Chart
From May 2024 to Jun 2024
LUMENIS LTD (NASDAQ:LMNS)
Historical Stock Chart
From Jun 2023 to Jun 2024